IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

TCG Crossover Management, LLC

Q4 2021 Holdings

Filed 2022-02-18 | 15 holdings | $39.5M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Cogent Biosciences, Inc.(COGT)COMMON STOCK19240Q201$23.6M2,750,03759.7%
Aclaris Therapeuitics, Inc.(ACRS)COMMON STOCK00461U105$15.7M1,082,21339.8%
Iveric Bio, Inc.(OPHTEUR)COMMON STOCK46583P102$29.1K1,741,2280.1%
Viridian Therapeutics Inc(VRDN)COMMON STOCK92790C104$26.0K1,314,0000.1%
Cymabay Therapeutics, Inc.(CBAYUSD)COMMON STOCK23257D103$20.0K5,905,4000.1%
Alpine Immune Sciences, Inc.(NVLSEUR)COMMON STOCK02083G100$16.2K1,170,2120.0%
Chinook Therapeutics, Inc.(290A)COMMON STOCK16961L106$14.4K882,3530.0%
Tyra Biosciences, Inc.(TYRA)COMMON STOCK90240B106$12.0K850,4500.0%
Entrada Therapeutics, Inc.(TRDA)COMMON STOCK29384C108$11.4K663,6940.0%
Aerovate Therapeutics, Inc.COMMON STOCK008064107$10.1K853,3300.0%
Magenta Therapeutics, Inc.COMMON STOCK55910K108$9.8K2,222,2220.0%
Akouos, Inc.COMMON STOCK00973J101$8.9K1,045,2150.0%
Merus N.V.COMMON STOCKN5749R100$7.2K225,0000.0%
Zai Lab Limited(ZLAB)COMMON STOCK98887Q104$6.0K95,0000.0%
Elevation Oncology, Inc.COMMON STOCK28623U101$3.3K555,0000.0%